Inapill的动态

Proud to share that my Seed-stage small molecule therapeutics start-up Inapill has been selected for the California Life Sciences (CLS) FAST California advisory program Spring 2025 cohort! As a 1st-time founder from academia spinning out a company based on ideas from my postdoc research on #immunometabolism, I very much look forward to leveraging the vast industry knowledge and expertise of Inapill’s FAST advisors over the next few months. Their gracious mentorship will undoubtedly strengthen our company’s strategic direction as we push to meet our Seed fundraising goals. And if you want to learn more about our 1st-in-class approaches to targeting #immunometabolism for improved treatment of inflammatory and autoimmune diseases, mark your calendars for June 4th - Inapill will pitch at the CLS Innovation Showcase at Bakar Bio Labs (home game!) along with the rest of the stellar FAST Spring 2025 cohort. So grateful for the support General Inception Dalriada Drug Discovery Bakar Bio Labs QB3 Joshua Farahzad Kevin Tharp, Ph.D. Eric Noel, PhD, MSc California Life Sciences (CLS) Shikha Sharma